Kunming Medical University
11 clinical trials · Sponsor
◉ Watch Kunming Medical University
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation (NCT06102928) | Kunming Medical University | 2023-10-30 |
| Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study (NCT05719038) | Kunming Medical University | 2023-01-30 |
| The Imaging Genetic Study of Type 2 Diabetes and Depression (NCT03564431) | Kunming Medical University | 2017-12-01 |
Track Kunming Medical University automatically
Every clearance here is in the API, with alerts when new ones post.